A prospective study on survival in cancer patients with and without venous thromboembolism

Internal and Emergency Medicine

Volumn 9, Issue 5, 2014, Pages 559-567

  Agnelli, Giancarlo ^a   Verso, Melina ^a   Mandalà, Mario ^b   Gallus, Silvano ^c   Cimminiello, Claudio ^d   Apolone, Giovanni ^e   Di Minno, Giovanni ^f   Maiello, Evaristo ^g   Prandoni, Paolo ^h   Santoro, Armando ⁱ   Crinò, Lucio ^j   Labianca, Roberto ^b  

^a UNIVERSITY OF PERUGIA   (Italy)

^b OSPEDALI RIUNITI   (Italy)

^c MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^d DESIO HOSPITAL   (Italy)

^e S MARIA NUOVA HOSPITAL   (Italy)

^f FEDERICO II UNIVERSITY HOSPITAL   (Italy)

^g CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^h UNIVERSITY OF PADOVA   (Italy)

ⁱ Humanitas Cancer Center   (Italy)

^j SANTA MARIA DELLA MISERICORDIA HOSPITAL   (Italy)

more..

Author keywords

Cancer; Deep venous thrombosis; Pulmonary embolism; Survival; Venous thromboembolism

Indexed keywords

AGED; CASE CONTROL STUDY; CLINICAL TRIAL; COMPLICATION; FEMALE; HUMAN; MALE; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; NEOPLASM; PROSPECTIVE STUDY; SURVIVAL RATE; VENOUS THROMBOEMBOLISM;

AGED; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PROSPECTIVE STUDIES; SURVIVAL RATE; VENOUS THROMBOEMBOLISM;

EID: 84904726817     PISSN: 18280447     EISSN: 19709366     Source Type: Journal    
DOI: 10.1007/s11739-013-0985-z     Document Type: Article

References (20)

1. Sorensen ET, Mellemkjaer L, Olsen JH et al (2000) Prognosis of cancers associated with venous thromboembolism. N Engl J Med 343: 1846-1850.
2. Falciani M, Imberti D, Prisco D (2006) Prophylaxis and treatment of venous thromboembolism in patients with cancer: an update. Intern Emerg Med 1(4): 273-278.
3. Wun T, White RH (2009) Venous thromboembolism in patients with cancer: epidemiology and risk factors. Cancer Invest 27(Suppl 1): 63-74.
4. Verso M, Agnelli G, Barni S et al (2012) A modified Khorana risk assessment score for venous thromboembolism in cancer patients receiving chemotherapy: the Protecht score. Intern Emerg Med 130(3): 369-373.
5. Alcalay A, Wun T, Khatri V et al (2006) Venous thromboembolism in patients with colorectal cancer: incidence and effect on survival. J Clin Oncol 24: 1112-1118.
6. Chew HK, Davies AM, Wun T (2008) The incidence of venous thromboembolism among patients with primary lung cancer. J Thromb Haemost 6: 601-608.
7. Chew HK, Wun T, Harvey D et al (2006) The incidence of venous thromboembolism and its effect on survival among patients with common cancer. Arch Intern Med 166: 458-464.
8. Chew HK, Wun T, Harvey DJ et al (2007) Incidence of venous thromboembolism and the impact on survival in breast cancer patients. J Clin Oncol 25: 70-76.
9. Starling N, Rao S, Cunningham D et al (2009) Thromboembolism in patients with advanced gastroesophageal cancer treated with anthracycline, platinum, and fluoropyrimidine combination chemotherapy: a report from the UK National Cancer Research Institute Upper Gastrointestinal Clinical Studies Group. J Clin Oncol 27: 3786-3793.
10. Mandala' M, Reni M, Cascinu S et al (2007) Venous thromboembolism predicts poor prognosis in irresectable pancreatic cancer patients. Ann Oncol 18: 1660-1665.
11. Sandhu R, Pan CX, Wun T et al (2010) The incidence of venous thromboembolism and its effect on survival among patients with primary bladder cancer. Cancer 116: 2596-2603.
12. Oken MM, Creech RH, Tormey DC et al (1982) Toxicity and response criteria of the Eastern cooperative oncology group. Am J Clin Oncol 5: 649-655.
13. Breslow NE, Day NE (1980) Statistical methods in cancer research. Volume I: the analysis of case-control studies. IARC Sci Publ 32: 5-338.
14. Bruzzi P, Green SB, Byar DP, Brinton LA, Schairer C (1985) Estimating the population attributable risk for multiple risk factors using case-control data. Am J Epidemiol 122: 904-914.
15. Benichou J, Gail MH (1990) Variance calculations and confidence intervals for estimates of the attributable risk based on logistic models. Biometrics 46: 991-1003.
16. den Exter PL, Hooijer J, Dekkers OM et al (2011) Risk of recurrent venous thromboembolism and mortality in patients with cancer incidentally diagnosed with pulmonary embolism: a comparison with symptomatic patients. J Clin Oncol 29: 2405-2409.
17. Dentali F, Ageno W, Pierfranceschi MG et al (2011) Prognostic relevance of an asymptomatic venous thromboembolism in patients with cancer. J Thromb Haemost 9: 1081-1083.
18. Sargent DJ, Köhne CH, Sanoff HK et al (2009) Pooled safety and efficacy analysis examining the effect of performance status on outcomes in nine first-line treatment trials using individual data from patients with metastatic colorectal cancer. J Clin Oncol 27: 1948-1955.
19. Mandalà M, Barni S, Floriani I et al (2009) Incidence and clinical implications of venous thromboembolism in advanced colorectal cancer patients: the 'GISCAD-alternating schedule' study findings. Eur J Cancer 45: 65-73.
20. Khorana AA, Kuderer NM, Culakova E et al (2008) Development and validation of a predictive model for chemotherapy-associated thrombosis. Blood 111: 4902-4907.